Open AccessRegarding “Oncology Drug Approvals: Evaluating Endpoints and Evidence in an Era of Breakthrough Therapies”
Author(s) -
Chabner Bruce A.
Publication year - 2017
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2017-0202
Subject(s) - medicine , food and drug administration , drug , drug approval , intensive care medicine , cancer drugs , drug development , oncology , pharmacology
This editorial reflects on improvements in the cancer drug approval process of the U.S. Food and Drug Administration.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom